Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Yumanity Therapeutics Inc (YMTX)

Yumanity Therapeutics Inc (YMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Yumanity Therapeutics Inc 40 GUEST STREET SUITE 4410 BOSTON MA 02135 USA

www.yumanity.com P: 617-409-5300

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Yumanity Therapeutics Inc. is a clinical-stage biopharmaceutical company involved in the treatment of neurodegenerative diseases. The company's product candidate includes YTX-7739.Yumanity Therapeutics Inc., formerly known as Proteostasis Therapeutics Inc., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 20,518
Enterprise Value, $K -2,812
Shares Outstanding, K 10,856
Float, K 9,504
% Float 87.55%
Short Volume Ratio 0.45
% of Insider Shareholders 12.45%
% of Institutional Shareholders 25.10%

Financials:

Annual Sales, $ 8,040 K
Annual Net Income, $ -39,500 K
Last Quarter Sales, $ 1,400 K
Last Quarter Net Income, $ -3,360 K

Growth:

1-Year Return -39.42%
3-Year Return -92.41%
5-Year Return -98.35%
5-Year Revenue Growth -4.06%
5-Year Earnings Growth 90.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 11/14/22
Next Earnings Date 03/23/23
Earnings Per Share ttm -3.00
EPS Growth vs. Prev Qtr 31.11%
EPS Growth vs. Prev Year 68.04%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 12/19/22

YMTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -263.34%
Return-on-Assets % -107.08%
Profit Margin % -491.29%
Debt/Equity 0.00
Price/Sales 2.35
Price/Cash Flow N/A
Price/Book 3.75
Book Value/Share 0.50
Interest Coverage -20.70
60-Month Beta 0.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar